Paris, France

Dominique Leguludec

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Dominique Leguludec

Introduction

Dominique Leguludec is a notable inventor based in Paris, France. He has made significant contributions to the field of molecular imaging, particularly in relation to serine proteases and their role in human pathologies. His work has implications for the diagnosis and understanding of various medical conditions.

Latest Patents

Dominique Leguludec holds a patent titled "Agents for the molecular imaging of serine-protease in human pathologies." This invention focuses on the use of an irreversible ligand of a serine protease, which includes leukocyte elastase, thrombin, tissue plasminogen activator (t-PA), and plasmin. The patent aims to enhance molecular imaging techniques for diagnosing pathophysiological conditions associated with serine protease activity. He has 1 patent to his name.

Career Highlights

Throughout his career, Dominique has worked with esteemed organizations such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and Pharmaleads. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Dominique has collaborated with notable colleagues, including Jean-Baptiste Michel and François Rouzet. These partnerships have enriched his research and expanded the impact of his work in the field of molecular imaging.

Conclusion

Dominique Leguludec's innovative work in molecular imaging and his contributions to understanding serine proteases highlight his importance as an inventor. His patent and collaborations reflect his commitment to advancing medical science and improving diagnostic techniques.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…